Effect of Stribild in the Treatment of AIDs
- VernacularTitle:Stribild治疗艾滋病的疗效
- Author:
Zhifang RAO
;
Wangang WANG
;
Zhi WANG
;
Jing TU
- Publication Type:Journal Article
- Keywords:
Stribild;
Elvitegravir;
Cobicistat;
Emtricitabine;
Tenofovir;
AIDs
- From:
China Pharmacist
2016;19(3):563-565
- CountryChina
- Language:Chinese
-
Abstract:
Stribild is a compound preparation composed of elvitegravir, cobicistat, emtricitabine and tenofovir. As for the first-treated AIDs patients or re-treated patients with creatinine clearance≥70ml·min-1 , it has definite clinical effect. Owing to once a day, stribild can enhance the acceptability of the patients, and as for the patients treated with other regimen complicated with diarrhea, pain in stomach and numbness in hands and feet, it also provides a good option. However, its adverse effects on kidney, liver and bone density in the long term use should be paid attention.
